89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients. (Q53057899)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients. |
scientific article |
Statements
89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients (English)
Sietske B M Gaykema
Carolien P Schröder
Joanna Vitfell-Rasmussen
Sue Chua
Thijs H Oude Munnink
Adrienne H Brouwers
Alfons H H Bongaerts
Mikhail Akimov
Cristina Fernandez-Ibarra
Marjolijn N Lub-de Hooge
1 reference